Studies focused on Parkinson’s disease have described the role of parkin in controlling dopamine utilization in human midbrain dopaminergic neurons and, among others, suppression of monoamine oxidase (MAO) by degrading estrogen-related receptors. The gene discussed is PRKN; the disease is Parkinson disease.